- Home
- TERN vs ACTG Comparison
TERN vs ACTG Comparison
Compare TERN & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- ACTG
- Stock Information
- Founded
- TERN 2017
- ACTG 1993
- Country
- TERN United States
- ACTG United States
- Employees
- TERN N/A
- ACTG N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- TERN Health Care
- ACTG Miscellaneous
- Exchange
- TERN Nasdaq
- ACTG Nasdaq
- Market Cap
- TERN 321.4M
- ACTG 363.5M
- IPO Year
- TERN 2021
- ACTG 1996
- Fundamental
- Price
- TERN $4.45
- ACTG $3.74
- Analyst Decision
- TERN Buy
- ACTG
- Analyst Count
- TERN 5
- ACTG 0
- Target Price
- TERN $15.63
- ACTG N/A
- AVG Volume (30 Days)
- TERN 902.6K
- ACTG 162.7K
- Earning Date
- TERN 08-04-2025
- ACTG 08-07-2025
- Dividend Yield
- TERN N/A
- ACTG N/A
- EPS Growth
- TERN N/A
- ACTG N/A
- EPS
- TERN N/A
- ACTG N/A
- Revenue
- TERN N/A
- ACTG $222,414,000.00
- Revenue This Year
- TERN N/A
- ACTG $141.36
- Revenue Next Year
- TERN N/A
- ACTG N/A
- P/E Ratio
- TERN N/A
- ACTG N/A
- Revenue Growth
- TERN N/A
- ACTG 65.22
- 52 Week Low
- TERN $1.87
- ACTG $2.70
- 52 Week High
- TERN $11.40
- ACTG $5.70
- Technical
- Relative Strength Index (RSI)
- TERN 65.96
- ACTG 55.84
- Support Level
- TERN $3.67
- ACTG $3.52
- Resistance Level
- TERN $4.39
- ACTG $3.79
- Average True Range (ATR)
- TERN 0.31
- ACTG 0.12
- MACD
- TERN 0.01
- ACTG -0.00
- Stochastic Oscillator
- TERN 91.67
- ACTG 68.57
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.